Stay updated on UBX1325 Safety in Macular Disease Clinical Trial

Sign up to get notified when there's something new on the UBX1325 Safety in Macular Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the UBX1325 Safety in Macular Disease Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    An NIH-wide banner announces a website transition and says some NIH content may use “Super Intelligence” instead of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-26T16:07:47.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T20:59:51.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer’s revision number changed from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-13T04:07:30.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The study page displays a 403 Forbidden message with a Home link instead of study information.
    Difference
    0.5%
    Check dated 2026-10-05T20:32:36.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page with a minimal header and footer, replacing the previous content that described or displayed the study record.
    Difference
    16%
    Check dated 2026-09-21T20:55:24.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Updated the page's revision tag from v3.6.5 to v3.6.6. This indicates a minor maintenance update rather than any substantive change to the page content or functionality.
    Difference
    0.1%
    Check dated 2026-08-31T16:37:03.000Z thumbnail image

Stay in the know with updates to UBX1325 Safety in Macular Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the UBX1325 Safety in Macular Disease Clinical Trial page.